Vergoeding 2019-2023 voor ATC-subgroep L01FA : Cd20-remmers
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021* | 2022* | 2023* | |
|---|---|---|---|---|---|
| L01FA01 Rituximab | 40.489.871 | 31.733.849 | 25.285.754 | 18.043.938 | 16.295.725 |
| L01FA02 Ofatumumab | 7.428 | . | . | . | . |
| L01FA03 Obinutuzumab | 2.906.314 | 2.769.680 | 3.186.781 | 3.379.445 | 3.289.792 |
| Totaal | 43.403.613 | 34.503.528 | 28.472.535 | 21.423.383 | 19.585.517 |